Sanofi’s Vaccine Lineup Gets a Shot in the Arm With $2.2B Dynavax Acquisition
Dynavax Technologies brings Sanofi a commercialized hepatitis B vaccine and a clinical-stage shingles vaccine, both…
Dynavax Technologies brings Sanofi a commercialized hepatitis B vaccine and a clinical-stage shingles vaccine, both of which offer differentiation from products marketed by GSK. It’s Sanofi’s second billion-dollar vaccines acquisition of 2025. The post Sanofi’s Vaccine Lineup Gets a Shot in the Arm With $2.2B Dynavax Acquisition appeared first on MedCity News.
Affordability, drug costs and AI will be top of mind for employers in 2026, according to Morgan Health CEO Dan Mendelson. The post Morgan Health: 5 Predictions for Employer-Sponsored Insurance in 2026 appeared first on MedCity News.
New tools and evidence can empower early action against Alzheimer’s before symptoms strike The post Knowledge Is Power: How Early Detection Can Transform Alzheimer’s Care appeared first on MedCity News.
Through intentional design, renewable energy investments and a deep commitment to innovation and efficiency, we can redefine what responsible growth looks like. The post Growth Without Compromise: Building The Future of Medicines Sustainably appeared first on MedCity News.
Rural Emergency Hospitals (REHs) are a new Medicare provider type created to preserve essential emergency and outpatient access in rural communities where low inpatient volume makes full-service hospitals financially unsustainable. They receive enhanced outpatient payments and a fixed monthly facility payment in exchange for forgoing acute inpatient care. CMS has an REH fact sheet that…
Valerie Health’s financing was led by Redpoint Ventures and included participation from General Catalyst, Primary VC, BoxGroup, Karman Ventures, .406 Ventures and Waybury Capital. The post Valerie Health Snags $30M to Advance AI Front Office for Independent Provider Groups appeared first on MedCity News.
New research shows that while health systems are pouring money into AI tools, most are still struggling to use the technology to meaningfully engage patients. Moving beyond generic outreach to “N-of-1 personalization” could be key to closing engagement gaps and improving patient outcomes at scale, said Amy Bucher, chief behavioral officer at Lirio. The post…
Beyond weight reduction and long-term maintenance of weight loss, the FDA decision for oral Wegovy covers use of the once-daily pill for reducing the risk of major cardiovascular events. Novo Nordisk expects the Wegovy tablet will launch in early January. The post Novo Nordisk’s Wegovy Pill Becomes First FDA-Approved Oral GLP-1 Drug for Weight Loss…
As healthcare embraced digital transformation in 2025, it encountered significant disruptions, from ransomware to policy uncertainty
We should never wait for tragedies to force a conversation around clear governance and accountability. Oversight has to evolve alongside innovation to protect people before harm occurs. The post When Innovation Outpaces Oversight: Lessons from IV Spas to AI appeared first on MedCity News.